Home › Pulmonary Fibrosis › North Carolina
Pulmonary Fibrosis clinical trials in North Carolina
3 studies for Pulmonary Fibrosis are looking for participants at sites in North Carolina.
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- UNC Chapel Hill, Chapel Hill
- Duke University, Durham
- Pulmonix LLC, Greensboro
- and 1 more
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jul 28, 2026 · NCT06325696Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Southeastern Research Center, Winston-Salem
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.